Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Akili Interactive Labs Inc.

www.akiliinteractive.com

Latest From Akili Interactive Labs Inc.

Asia Deal Watch: Athenex Changes Mind, Gets Back Chinese Rights To Actinic Keratosis Candidate

Following a positive Phase III data readout for KX2-391, Athenex requests dissolution of its recent deal conferring rights to the drug in China to Chongqing Jingdong Junzhuo. TaiwanJ licenses Asian rights outside its home market for JK-122 to Newsoara.
Asia Pacific Deals

Deal Watch: Oncternal Goes Public Via Reverse Merger With GTx

All-stock transaction combines privately held Oncternal with GTx, which had been considering its strategic alternatives. Biogen acquires gene therapy biotech Nightstar, MaxCyte and Kite expand their CAR-T partnership.

Deals Business Strategies

Akili Strikes $125m Digital Med Deal With Japanese Partner

PureTech Health's Akili has announced a $125m partnership with Japanese pharmaceutical company Shionogi to commercialize two of its digital therapeutics in Japan and Taiwan.

Digital Health Neurology

Shionogi Builds Digital Therapeutics Presence Through Akili Alliance

Shionogi has become the latest Japanese company to build its presence in the digital health realm, this time through an alliance with Akili for two novel digital therapeutics.

Japan Business Strategies
See All

Company Information

  • Industry
  • Digital Health
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
    • Rehabilitation Equipment and Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Akili Interactive Labs Inc.
  • Senior Management
  • Eddie Martucci, PhD, CEO
    Vincent Hennemand, VP, Strategy, Corp. & BD
  • Contact Info
  • Akili Interactive Labs Inc.
    125 Broad St
    4th Fl.
    Boston, MA 02110
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register